Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

SERA PROGNOSTICS, INC.

(SERA)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Sera Prognostics Inc. Appoints Paul Kearney as Chief Data Officer

09/28/2021 | 08:30am EST

Sera Prognostics Inc. announced the appointment of Dr. Paul Kearney to the position of Chief Data Officer, effective October 1, 2021. As the chief data/analytics officer, Dr. Kearney will have responsibility to help direct, manage and analyze the large and growing data sets of the company, both scientific and business, as the company engages in studies designed to more fully characterize pregnancy and as commercial activities ramp during this phase of the company’s development. Prior to joining the company, Dr. Kearney co-founded multiple successful biotech companies and data enterprises, resulting in the development and commercialization of breakthrough products in the disease areas of oncology, pregnancy, and food allergy, as well as technological products in bioinformatics and proteomics. He has extensive experience building and nurturing integrated teams, conducting clinical research, developing evidence for improved health outcomes, and fund raising.


© S&P Capital IQ 2021
All news about SERA PROGNOSTICS, INC.
12/02Sera Prognostics Inc. Announces Pricing for PreTRM? Test, the Only Broadly Validated Bl..
CI
12/01Sera Prognostics Says Study Confirms Performance of Its Biomarkers to Address Preterm B..
MT
12/01Sera Prognostics Announces Publication Of Data Confirming The Performance Of The IBP4/S..
PR
11/30SERA PROGNOSTICS, INC. : Change in Directors or Principal Officers (form 8-K)
AQ
11/30Sera Prognostics, Inc. Appoints Sandra A. J. Lawrence to Board of Directors
CI
11/09SERA PROGNOSTICS REPORTS THIRD QUARTER 2021 FINANCIAL RESULTS - Form 8-K
PU
11/09SERA PROGNOSTICS, INC. Management's Discussion and Analysis of Financial Condition and..
AQ
11/09Earnings Flash (SERA) SERA PROGNOSTICS Posts Q3 Revenue $23,000
MT
11/09Sera Prognostics Reports Third Quarter 2021 Financial Results
PR
11/09Sera Prognostics, Inc. Announces Unaudited Earnings Results for the third Quarter and n..
CI
More news
Analyst Recommendations on SERA PROGNOSTICS, INC.
More recommendations
Financials (USD)
Sales 2021 0,19 M - -
Net income 2021 -31,5 M - -
Net Debt 2021 - - -
P/E ratio 2021 -4,76x
Yield 2021 -
Capitalization 308 M 308 M -
Capi. / Sales 2021 1 596x
Capi. / Sales 2022 46,0x
Nbr of Employees 73
Free-Float 85,1%
Chart SERA PROGNOSTICS, INC.
Duration : Period :
Sera Prognostics, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 4
Last Close Price 10,04 $
Average target price 18,50 $
Spread / Average Target 84,3%
EPS Revisions
Managers and Directors
Gregory C. Critchfield Chairman, President & Chief Executive Officer
Jay M. Moyes Chief Financial Officer
John J. Boniface Chief Scientific Officer
Thomas J. Garite Vice President-Clinical Sciences
Robert Gardner Harrison Chief Information Officer